Literature DB >> 14218302

IMMUNITY TO TRANSPLANTABLE TUMORS FOLLOWING VIRAL ONCOLYSIS. I. MECHANISM OF IMMUNITY TO EHRLICH ASCITES TUMOR.

J LINDENMANN.   

Abstract

Entities:  

Keywords:  ANTIBODIES; CARCINOMA, EHRLICH TUMOR; EXPERIMENTAL LAB STUDY; IMMUNE SERUMS; INFLUENZA VIRUSES; MICE; NEOPLASM IMMUNOLOGY; ONCOLYTIC VIRUSES; PHYSIOLOGY; SPLEEN

Mesh：

Substances：

Year:  1964        PMID： 14218302

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  8 in total

1.  Tumor immunity after viral oncolysis.

Authors:  W A Cassel; R E Garrett
Journal:  J Bacteriol       Date:  1966-09       Impact factor: 3.490

2.  Physicochemical membrane changes in Ehrlich ascites tumor cells infected with oncolytic influenza virus.

Authors:  K O Fresen; A Dübendorfer
Journal:  Arch Gesamte Virusforsch       Date:  1973

3.  [Comparative studies on influenza virus proteins].

Authors:  H Koblet
Journal:  Experientia       Date:  1971-02-15

4.  Tumor-associated transplantation antigens in immune rejection of mouse malignant cell hybrids.

Authors:  J Jami; E Ritz
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

5.  Morphogenesis of influenza A virus in Ehrlich ascites tumor cells as revealed by thin-sectioning and freeze-etching.

Authors:  T Bächi; W Gerhard; J Lindenmann; K Mühlethaler
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

6.  Immune responses of mice to iodoacetate-treated Ehrlich ascites tumour cells.

Authors:  M Wang; W J Halliday
Journal:  Br J Cancer       Date:  1967-06       Impact factor: 7.640

7.  The effect of neuraminidase on the immunogenicity of the Landschütz ascites tumour: site and mode of action.

Authors:  G A Currie; K D Bagshawe
Journal:  Br J Cancer       Date:  1968-09       Impact factor: 7.640

8.  Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus.

Authors:  J Lindenmann; P A Klein
Journal:  J Exp Med       Date:  1967-07-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.